Clinical Application of Two Novel Rapid Bedside Tests for the Detection of Cardiac Troponin T and Creatine Kinase-MB Mass/Myoglobin in Whole Blood in Acute Myocardial Infarction
- 1 March 1998
- journal article
- research article
- Published by S. Karger AG in Cardiology
- Vol. 89 (3) , 222-228
- https://doi.org/10.1159/000006791
Abstract
The objective of this study was to determine whether two novel rapid bedside assays for whole-blood detection of cardiac troponin T and creatine kinase (CK)-MB mass/myoglobin could rule out or rule in acute myocardial infarction in patients with acute chest pain. Ninety-two patients with chest pain <12 h prior to admission were investigated. No difference in the cumulative sensitivity of the TropT test and the CARDIAC STATus test (CK-MB mass and myoglobin in combination) was found 6 h after admission (94 vs. 97%). The cumulative positive predictive value of the TropT test and CARDIAC STATus test 6 h after admission was 97 and 76%, respectively. The negative predictive value was 97% for the TropT test and 98% for the CARDIAC STATus test at this time point. Our data show that the rapid assays provide diagnostic as well as prognostic information shortly after admission.This publication has 4 references indexed in Scilit:
- Troponin T Identifies Patients With Unstable Coronary Artery Disease Who Benefit From Long-Term Antithrombotic ProtectionJournal of the American College of Cardiology, 1997
- Cardiac Troponin T Levels for Risk Stratification in Acute Myocardial IschemiaNew England Journal of Medicine, 1996
- Rapid bedside whole blood cardiospecific troponin T immunoassay for the diagnosis of acute myocardial infarctionThe American Journal of Cardiology, 1995
- Electrocardiographic and clinical criteria for recognition of acute myocardial infarction based on analysis of 3,697 patientsThe American Journal of Cardiology, 1983